__timestamp | ADMA Biologics, Inc. | ImmunityBio, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 9517014 | 1595000 |
Thursday, January 1, 2015 | 7015946 | 11434000 |
Friday, January 1, 2016 | 7688238 | 26546000 |
Sunday, January 1, 2017 | 6229587 | 39778000 |
Monday, January 1, 2018 | 3926120 | 53418000 |
Tuesday, January 1, 2019 | 2343848 | 111997000 |
Wednesday, January 1, 2020 | 5907013 | 139507000 |
Friday, January 1, 2021 | 3646060 | 195958000 |
Saturday, January 1, 2022 | 3613764 | 248149000 |
Sunday, January 1, 2023 | 3300000 | 232366000 |
Data in motion
In the ever-evolving landscape of biotechnology, research and development (R&D) expenses serve as a critical indicator of a company's commitment to innovation. Over the past decade, ADMA Biologics, Inc. and ImmunityBio, Inc. have demonstrated contrasting trajectories in their R&D investments.
From 2014 to 2023, ImmunityBio, Inc. has shown a staggering increase in R&D expenses, growing by over 14,500% from 2014 to 2022, peaking at approximately $248 million. This reflects their aggressive pursuit of cutting-edge therapies. In contrast, ADMA Biologics, Inc. has seen a more modest decline of around 65% in the same period, with expenses dropping from $9.5 million in 2014 to $3.3 million in 2023.
These trends highlight the diverse strategies employed by biotech firms in navigating the challenges and opportunities of the industry.
Comparing Innovation Spending: Eli Lilly and Company and ADMA Biologics, Inc.
R&D Insights: How Summit Therapeutics Inc. and ADMA Biologics, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Halozyme Therapeutics, Inc. and ADMA Biologics, Inc.
Axsome Therapeutics, Inc. or ADMA Biologics, Inc.: Who Invests More in Innovation?
Research and Development Investment: Alpine Immune Sciences, Inc. vs ImmunityBio, Inc.
Analyzing R&D Budgets: ADMA Biologics, Inc. vs Apellis Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: ADMA Biologics, Inc. vs Amicus Therapeutics, Inc.
Analyzing R&D Budgets: ADMA Biologics, Inc. vs Amphastar Pharmaceuticals, Inc.
R&D Insights: How ADMA Biologics, Inc. and MiMedx Group, Inc. Allocate Funds
R&D Spending Showdown: CymaBay Therapeutics, Inc. vs ImmunityBio, Inc.
Comparing Innovation Spending: Xenon Pharmaceuticals Inc. and ImmunityBio, Inc.
Analyzing R&D Budgets: ImmunityBio, Inc. vs Travere Therapeutics, Inc.